Erratum for Kähler and Colleselli,
Erratum for Kuhn et al.,
Erratum for Kolb-Bachofen et al.,
Erratum for Loser and Beissert,
Erratum for Zuber and Spertini,
Erratum for Distler et al.,
Erratum for Foeldvari,
Erratum for Gaubitz,
Erratum for Saar et al.,
Erratum for Sunderkötter and Riemekasten,
Erratum for Richter,
Erratum for Neuhofer and Pittrow,
Erratum for Blank et al.,
Erratum for Selenko-Gebauer et al.,
Erratum for Riemekasten and Sunderkötter,
Erratum for Fischer-Betz and Schneider,
Erratum for Sunderkötter et al.,
Erratum for Sticherling,
Rheumatology 2008 47(2):234-235; doi:10.1093/rheumatology/kem349
Erratum
Connective Tissue Diseases, Rheumatology 2006;45(Suppl 3):iii1–54The publisher wishes to apologize for inadvertently not publishing full disclosure statements and for the problems this caused listing the articles on PubMed. The disclosure statements for the manuscripts from this supplement should have been as follows:
O. Distler and U. Müller-Ladner
Novel aspects in the epidemiology, pathophysiology and treatment of connective tissue diseases
Rheumatology 2006;45:iii1–2; doi:10.1093/rheumatology/kel279
Disclosure statement: U.M.-L. and O.D. received speaker honoraria for participation at the Actelion Winter School 2006.
M. Gaubitz
Epidemiology of connective tissue disorders
Rheumatology 2006;45:iii3–4; doi:10.1093/rheumatology/kel282
Disclosure statement: The author received a speaker's honorarium for participation at the Actelion Winter School 2006.
R. Fischer-Betz and M. Schneider
Connective tissue diseases: evaluation of clinical response
Rheumatology 2006;45:iii5–7; doi:10.1093/rheumatology/kel281
Disclosure statement: The authors have declared no conflicts of interest.
M. Sticherling
The role of endothelin in connective tissue diseases
Rheumatology 2006;45:iii8–10; doi:10.1093/rheumatology/kel294
Disclosure statement: The author received a speaker's honorarium for participation at the Actelion Winter School 2006.
C. M. Kähler and D. Colleselli
Pulmonary arterial hypertension (PAH) in connective tissue diseases
Rheumatology 2006;45:iii11–13; doi:10.1093/rheumatology/kel291
Disclosure statement: C.M.K. received a speaker's honorarium for participation at the Actelion Winter School 2006 and received research support from Actelion. The other author declared no conflicts of interest.
A. Kuhn, P. H. Krammer and V. Kolb-Bachofen
Pathophysiology of cutaneous lupus erythematosus—novel aspects
Rheumatology 2006;45:iii14–16; doi:10.1093/rheumatology/kel284
Disclosure statement: A.K. received a speaker's honorarium for participation at the Actelion Winter School 2006. All other authors declared no conflicts of interest.
V. Kolb-Bachofen, A. Kuhn and C. V. Suschek
The role of nitric oxide
Rheumatology 2006;45:iii17–19; doi:10.1093/rheumatology/kel287
Disclosure statement: V.K.-B. and A.K. received speaker honoraria for participation at the Actelion Winter School 2006. The other author declared no conflicts of interest.
K. Loser and S. Beissert
Therapeutic modulation of cutaneous autoimmunity by regulatory T cells
Rheumatology 2006;45:iii20–22; doi:10.1093/rheumatology/kel286
Disclosure statement: S.B. received a speaker's honorarium for participation at the Actelion Winter School 2006. The other author declared no conflicts of interest.
J.-P. Zuber and F. Spertini
Immunological basis of systemic sclerosis
Rheumatology 2006;45:iii23–25; doi:10.1093/rheumatology/kel285
Disclosure statement: J.-P.Z. received a speaker's honorarium for participation at the Actelion Winter School 2006. The other author declared no conflicts of interest.
J. H. W. Distler, S. Gay and O. Distler
Angiogenesis and vasculogenesis in systemic sclerosis
Rheumatology 2006;45:iii26–27; doi:10.1093/rheumatology/kel295
Disclosure statement: O.D. received a speaker's honorarium for participation at the Actelion Winter School 2006. All other authors declared no conflicts of interest.
I. Foeldvari
Systemic sclerosis in childhood
Rheumatology 2006;45:iii28–29; doi:10.1093/rheumatology/kel292
Disclosure statement: The author received a speaker's honorarium for participation at the Actelion Winter School 2006.
P. Saar, W. Hermann and U. Müller-Ladner
Connective tissue diseases and pregnancy
Rheumatology 2006;45:iii30–32; doi:10.1093/rheumatology/kel288
Disclosure statement: U.M.-L. received a speaker's honorarium for participation at the Actelion Winter School 2006. All other authors declared no conflicts of interest.
C. Sunderkötter and G. Riemekasten
Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosis
Rheumatology 2006;45:iii33–35; doi:10.1093/rheumatology/kel280
Disclosure statement: C.S. and G.R. received speaker honoraria for participation at the Actelion Winter School 2006.
C. M. Richter
Role of endothelin in chronic renal failure—developments in renal involvement
Rheumatology 2006;45:iii36–38; doi:10.1093/rheumatology/kel278
Disclosure statement: The author received a speaker's honorarium for participation at the Actelion Winter School 2006.
W. Neuhofer and D. Pittrow
Endothelin in human autoimmune diseases with renal involvement
Rheumatology 2006;45:iii39–41; doi:10.1093/rheumatology/kel277
Disclosure statement: The authors have declared that the work was supported by an unrestricted educational grant from Actelion Pharmaceuticals.
N. Blank, R. Max and H.-M. Lorenz
The role of DMARDs in systemic sclerosis therapy
Rheumatology 2006;45:iii42–44; doi:10.1093/rheumatology/kel289
Disclosure statement: N.B. received a speaker's honoraria for participation at the Actelion Winter School 2006. All other authors declared no conflicts of interest.
N. Selenko-Gebauer, N. Duschek, G. Minimair, G. Stingl and F. Karlhofer
Successful treatment of patients with severe secondary Raynaud's phenomenon with the endothelin receptor antagonist bosentan
Rheumatology 2006;45:iii45–48; doi:10.1093/rheumatology/kel290
Disclosure statement: F.K. received a speaker's honorarium for participation at the Actelion Winter School 2006. All other authors declared no conflicts of interest.
G. Riemekasten and C. Sunderkötter
Vasoactive therapies in systemic sclerosis
Rheumatology 2006;45:iii49–51; doi:10.1093/rheumatology/kel283
Acknowledgements
The article was supported by the German network for systemic sclerosis founded by the BMBF network of rare diseases as well as from the European Systemic Sclerosis Trial and Research program (EUSTAR).
Disclosure statement: C.S. and G.R. received speaker honoraria for participation at the Actelion Winter School 2006.
C. Sunderkötter, A. Kuhn, N. Hunzelmann and S. Beissert
Phototherapy: a promising treatment option for skin sclerosis in scleroderma?
Rheumatology 2006;45:iii52–54; doi:10.1093/rheumatology/kel293
Disclosure statement: All authors received speaker honoraria for participation at the Actelion Winter School 2006.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||